Qiagen's 1Q14 financial results top Street

Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) reports 1Q14 financial results late Tuesday that beat the Street and unveiled a new $100 million share repurchase program slated to start later this year. The sample and assay technology supplier reported 1Q14 adjusted diluted EPS of $0.22, above the Street's $0.20 estimate and up from $0.20 in the prior year's quarter. Adjusted net sales in the quarter were $317.4 million, up 5% at constant exchange rates from $303.6 million in 1Q13 and beating the Street's $316.9 million estimate.

Qiagen reiterated its 2014 guidance of net sales growth of 4-5% at constant exchange rates over 2013 and adjusted diluted EPS of $1.07-$1.09. The company reported 2013 adjusted net sales of $1.3 billion. The Street was expecting 2014 EPS of $1.09 on full-year sales of $1.4 billion. ...